Sunir Garg, MD, a professor of ophthalmology at Wills Eye Hospital and partner with Mid-Atlantic Retina, discussed with Modern Retina one significant challenge in ophthalmological procedures: patient ...

Katherine Talcott, a retina specialist at Cole Eye Institute at the Cleveland Clinic, presented at the Retinal World Congress 2025 meeting. In her presentation and in her conversation with Modern ...

At Retina World Congress 2025, Dilsher S. Dhoot, MD, shares updates on the HELIOS trial and the potential future of tyrosine kinase inhibitors (TKIs). At the Retina World Congress 2025 in Lauderdale, ...

Carl D. Regillo, MD, Director of the Retina Service at Wills Eye Hospital and partner at Mid Atlantic Retina, met with Modern Retina at the 2025 Retina World Congress meeting held in Fort Lauderdale, ...

Alan J. Franklin, MD, PhD, spoke with Modern Retina at Retina World Congress 2025. This meeting is taking place in Fort Lauderdale, Florida, from May 8-11, 2025. In this conversation, Franklin ...

Alkeus Pharmaceuticals reveals promising Phase 2 SAGA study results, showing gildeuretinol slows vision decline in geographic atrophy linked to AMD. Seemi Khan, MD, MPH, MBA, Chief Medical Officer of ...

The phase 2 clinical trial data evaluating the efficacy, safety, and dosing intervals of high-dose IBI302 were presented during the annual 2025 ARVO meeting.

Modern Retina - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

According to Dr. Danzig, the DIAMOND trial demonstrates efficacy of OCS-01, a topical drop, in patients with diabetic macular edema. Carl Danzig, MD, director of vitreo-retinal services at the Rand ...

Isarna Therapeutics shared final positive results from the Phase 2 BETTER trial, which evaluated the candidate ISTH0036 to address retinal fibrosis. ISTH0036 is an investigational antisense ...